Partners
The SCI's major funding partners are the
Bill and Melinda Gates Foundation,
USAID, and Geneva Global. The home of SCI is the
Department of Infectious Disease
Epidemiology, Imperial College London;
and the major operational partners are the Ministries of Health and Education in
country. Additionally SCI has a special partnership with Riseal in West Africa,
a local NGO with long experience in these countries. The SCI works very closely
with the World Health Organization’s Department of Neglected Tropical Diseases
and ensures that schistosomiasis and neglected tropical diseases research and
control activities follow the WHO guidelines.
Our key advocacy and implementation partners currently are:
- GNNTDC – The Global Network in which SCI is a founding partner. GNNTDC
has a strong advocacy role worldwide to raise the profile of NTDs.
- ITI - who are responsible for Trachoma.
- RTI - who grant USAID funding to SCI.
- World Health Organization (WHO) – guiding authority for implementation
of NTD treatment.
- The United States Agency for
International Development (USAID)
- Liverpool School of Tropical Medicine – and their LF support centre.
- The Earth Institute - Rwanda
branch, which is the main implementer of the NTD Control Programme in
Rwanda.
- Helen Keller International – implementing partner in Mali.
- RISEAL – who assist us to manage our programmes in Burkina Faso and
Niger.
- CBM - which is the main partner of the
Ministry of Public Health for the implementation of the NTD Control
Programme in Burundi.
The SCI has worked and still works closely with a number of other
organisations:
- The World Food Programme - by assisting
the WFP to deliver deworming pills together with the food they provide
through the School Feeding programme.
- International Dispensary Association
(IDA), Holland, who provide high quality reasonably priced drugs especially
for the USAID funded NTD programme, to certain countries.
- The DBL Institute for Health
Research and Development, which has an excellent track record of
research and training in Africa. In particular DBL assisted SCI to reach the
goal of treating millions of people in Uganda by training health personnel
in 20 or more districts, and recently managed the SCI Schistosomiasis
Research Programme which granted small research funding to Southern research
partners.
- The Center for Disease Control,
Atlanta, (CDC) assisted SCI by providing an independent monitoring service
for measuring the achievements of the SCI.
- The Partnership for Child
Development (PCD), based in the same Department at Imperial College
London (DIDE), and SCI have overlapping mission statements, and have
collaborated and shared resources in several countries.
- African public and private organizations, and government ministries in
several implementing countries such as: Burkina Faso, Ghana, Níger, Mali,
Sudan, Tanzania, Uganda, Zambia; and possible implementing countries:
Cameroon, Kenya, Nigeria, Malawi.
- NIH, The
Wellcome Trust and
DFID are all donors who contribute or
have contributed directly or indirectly to the initiative against
schistosomiasis and NTDs by supporting research or control operations.
- The World Bank which through its
FRESH initiative (Focussing
Resources Effectively for School Health) and loans to developing countries
is pushing forward the school health programmes in many countries.
- The London School of Hygiene and
Tropical Medicine with the
Department of Infectious and Tropical Diseases. In particular Dr. Simon
Brooker assisted SCI in the development of surveillance maps, and use of GIS
technology as required in the SCI participating countries. The London School
also hosted an SCI staff member Dr. Archie Clements while he developed maps
of the countries for practical implementation use.
|
